ZAc 105.0
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -6.4 Million | -21.34 Million | -21.05 Million | -14.14 Million | 28.89 Million | -23.95 Million |
Net Income | -113.93 Million | -21.6 Million | -938.77 Million | -34.43 Million | 762.96 Million | 291.52 Million |
Depreciation & Amortization | 4.66 Million | 4.51 Million | 3.95 Million | 10.79 Million | 56.38 Million | 34.42 Million |
Deferred income taxes | - | - | - | 35.76 Million | -911.75 Million | -324.8 Million |
Stock-based compensation | - | - | 70 Thousand | 34.13 Million | 39.04 Million | 1.36 Million |
Change in working capital | 8.13 Million | 1.28 Million | -2.54 Million | 15.9 Million | 71.28 Million | -18.92 Million |
Other non-cash items | 95.92 Million | -5.54 Million | 916.24 Million | -76.31 Million | 10.97 Million | -7.53 Million |
Investing Cash Flow | 7.06 Million | 19.34 Million | 48.52 Million | 51.64 Million | -33.93 Million | 518.63 Million |
Investments in PPE | -3.13 Million | -3.97 Million | -4.48 Million | -4.67 Million | -68.73 Million | -96.66 Million |
Acquisitions | 59 Thousand | 3.84 Million | -3 Million | 10.96 Million | 35.24 Million | 596.19 Million |
Investment purchases | -17.22 Million | -2.92 Million | -4.53 Million | -17.53 Million | -1.74 Million | -16.23 Million |
Sales/Maturities of investments | 27.37 Million | 60.39 Million | 60.31 Million | 62.37 Million | 1.13 Million | 16.23 Million |
Other Investing Activities | 7.17 Million | -37.99 Million | 233 Thousand | 510 Thousand | 173 Thousand | 19.1 Million |
Financing Cash Flow | 6.7 Million | 5.53 Million | -33.83 Million | -43.81 Million | -214 Thousand | -396.44 Million |
Debt repayment | -17.8 Million | -6.5 Million | -44.47 Million | -42.37 Million | -54.89 Million | -31.14 Million |
Dividends payments | -10.1 Million | - | - | - | - | -343.79 Million |
Common Stock Repurchased | - | - | - | - | - | -15.79 Million |
Common Stock Issuance | - | - | - | - | 4.69 Million | -2.75 Million |
Other Financing Activities | -1 Million | 12.04 Million | 10.64 Million | -1.44 Million | 49.98 Million | -2.95 Million |
Accounts receivables | 4.27 Million | -442 Thousand | -3.59 Million | 9.47 Million | 22.44 Million | 62.64 Million |
Accounts payables | 3.85 Million | 1.72 Million | 2.39 Million | 6.53 Million | 34.27 Million | -60.39 Million |
Inventory | - | 295 Thousand | -1.34 Million | -101 Thousand | 14.56 Million | -21.17 Million |
Other working capital | 3.85 Million | -295 Thousand | - | - | - | - |
Cash at beginning of period | 4.73 Million | 1.19 Million | 7.55 Million | 13.87 Million | 19.12 Million | -79.1 Million |
Cash at end of period | 12.09 Million | 4.73 Million | 1.19 Million | 7.55 Million | 13.87 Million | 19.12 Million |
Capital Expenditure | -3.13 Million | -3.97 Million | -4.48 Million | -4.67 Million | -68.73 Million | -96.66 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 7.36 Million | 3.53 Million | -6.35 Million | -6.32 Million | -5.25 Million | 98.23 Million |
Free Cash Flow | -9.54 Million | -25.32 Million | -25.53 Million | -18.81 Million | -39.84 Million | -120.61 Million |
Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -51.36 Million | -113.93 Million | -51.36 Million | -11.21 Million | -5.6 Million | -21.6 Million |
Depreciation & Amortization | 1.19 Million | 4.66 Million | -267.5 Thousand | 2.26 Million | 1.13 Million | 4.51 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 2.13 Million | 8.13 Million | 2.13 Million | - | - | 1.28 Million |
Other non-cash items | 50.59 Million | 95.92 Million | 52.05 Million | 1.94 Million | -1.29 Million | -5.54 Million |
Investing Cash Flow | 4.06 Million | 7.06 Million | 4.06 Million | -1.06 Million | -532 Thousand | 19.34 Million |
Investments in PPE | -28.5 Thousand | -3.13 Million | -28.5 Thousand | -1.62 Million | -25 Thousand | -3.97 Million |
Acquisitions | 59 Thousand | 59 Thousand | - | 507 Thousand | - | 3.84 Million |
Investment purchases | -7.72 Million | -17.22 Million | - | -9.5 Million | - | -2.92 Million |
Sales/Maturities of investments | 17.3 Million | 27.37 Million | - | 10.06 Million | - | 60.39 Million |
Other Investing Activities | 4.09 Million | 7.17 Million | 4.09 Million | -507 Thousand | -507 Thousand | -37.99 Million |
Financing Cash Flow | -8.7 Million | 6.7 Million | -8.7 Million | 24.1 Million | 12.05 Million | 5.53 Million |
Debt repayment | -5.57 Million | -17.8 Million | - | -23.38 Million | - | -6.5 Million |
Dividends payments | -5.05 Million | -10.1 Million | -5.05 Million | - | - | - |
Common Stock Repurchased | -360 Thousand | - | -360 Thousand | - | - | - |
Common Stock Issuance | -720 Thousand | - | - | 720 Thousand | - | - |
Other Financing Activities | -3.28 Million | -1 Million | -3.28 Million | 12.05 Million | 12.05 Million | 12.04 Million |
Accounts receivables | 2.13 Million | 4.27 Million | 2.13 Million | - | - | -442 Thousand |
Accounts payables | - | 3.85 Million | - | - | - | 1.72 Million |
Inventory | - | - | - | - | - | 295 Thousand |
Other working capital | - | - | - | - | - | -295 Thousand |
Cash at beginning of period | 16.23 Million | 4.73 Million | - | 4.73 Million | - | 1.19 Million |
Cash at end of period | 12.09 Million | 12.09 Million | -2.06 Million | 16.23 Million | 5.75 Million | 4.73 Million |
Capital Expenditure | -28.5 Thousand | -3.13 Million | -28.5 Thousand | -1.62 Million | -25 Thousand | -3.97 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -4.13 Million | 7.36 Million | -2.06 Million | 11.5 Million | 5.75 Million | 3.53 Million |
Free Cash Flow | 2.53 Million | -9.54 Million | 2.53 Million | -13.16 Million | -5.79 Million | -25.32 Million |
IMMX
ZODIAC
THEMISMED
CRDL
4215
WKPPF